CEO and Founder of Anterios, Inc., Jon Edelson, MD, will be presenting at Needham & Company's 12th Annual Healthcare Conference in New York City on April 30, 2013. In other company news, Anterios also recently received an $8.5 million round of financing for the development and progress of their topical botulinum product, ANT-1207, currently in Phase IIb clinical trials for wrinkles, hyperhidrosis, and acne.